Before TR 82, many manufacturers relied on legacy validation data that might not meet modern scrutiny. TR 82 is essential because:
Published in March 2019, PDA Technical Report No. 82 (TR 82) established standardized protocols for managing Low Endotoxin Recovery (LER), a phenomenon where endotoxins in biopharmaceuticals become masked and undetectable. The report, developed by a PDA task force, provides scientifically sound methods for hold-time studies and mitigation strategies to address this safety risk, which is now recognized by global regulators. Read more at PDA Bookstore Technical Report No. 82: Low Endotoxin Recovery | PDA pda technical report 82 pdf
: Premium members may be eligible for a free annual technical document download by contacting the association directly. Parenteral Drug Association Overview of TR 82 Content Format: PDF and hard copy
TR-82 provides a risk-based framework for validating filters that achieve sterility or low bioburden levels without destroying the product. Published in March 2019, PDA Technical Report No
The , titled "Low Endotoxin Recovery (LER)," is a definitive industry guide for understanding and managing the masking of endotoxins in biopharmaceutical products.